Загрузка...
Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen
The Tamoxifen Response by CYP2D6 Genotype‐based Treatment‐1 (TARGET‐1) study (n = 180) was conducted from 2012–2017 in Japan to determine the efficacy of tamoxifen dosing guided by cytochrome P450 2D6 (CYP2D6) genotypes. To predict its outcomes prior to completion, we constructed the comprehensive p...
Сохранить в:
| Опубликовано в: : | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6063740/ https://ncbi.nlm.nih.gov/pubmed/29920987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12307 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|